Fady Ibraham Malik Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

Fady Ibraham Malik is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 30,000 shares of RCKT, which is worth approximately $100,200. The most recent transaction as insider was on Jun 18, 2025, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K

n/a 3M change

n/a 12M change

Total Value Held $100,200

Fady Ibraham Malik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 18 2025	BUY Grant, award, or other acquisition	-	30,000 Added 50.0%	30,000 Common Stock

Also insider at

CYTK

CYTOKINETICS INC Healthcare

EVP Research & Development

FIM